Articles published by Immix Biopharma, Inc.Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Immix Biopharma Doses Additional Patients in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
January 13, 2023
Via GlobeNewswire
Tickers
IMMX
Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
December 20, 2022
Via GlobeNewswire
Tickers
IMMX
Via GlobeNewswire
Tickers
IMMX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|